Hirschsprung-associated enterocolitis (HAEC) is a common life-threatening complication of Hirschsprung disease (HSCR). It has been proposed that gut microbiota, which have an essential role in gut-homeostasis, are associated with HAEC. Recent studies demonstrated an increase in alpha diversity of fecal microbiota over time in HSCR mice and a decrease in diversity after surgery. In addition, clinical studies have reported a reduction in bacterial richness in HSCR children after surgery. Some studies revealed a difference in microbiota between the proximal ganglionic and distal aganglionic intestine and found a difference in bacterial character between fecal and colonic specimens. HAEC studies found an increase in Proteobacteria, especially Escherichia and Enterobacteriaceae, with a decrease in Firmicutes and Bifidobacterium in HAEC patients. However, the direction of alpha diversity in HAEC patients is still controversial. The self-comparison of microbiota in treatment periods suggested that probiotics might improve gut dysbiosis and decrease the frequency of enterocolitis, but some reported contradictory findings. This review comprehensively summarizes and discusses key findings from animal and clinical data of the distinct microbiome associated with HCSR and the association of gut dysbiosis with the development of HAEC. This information should be useful in the establishment of novel interventions to improve gut dysbiosis and prevent enterocolitis in HSCR patients.
Background: Rectus sheath block (RSB) provides reliable anesthesia to the anteromedial abdominal wall and may offer effective pain control following laparoscopic sleeve gastrectomy (LSG). This study aimed to compare the efficacy of RSB versus local infiltration analgesia (LIA), hypothesizing that RSB would provide superior pain relief. Methods: In this randomized controlled trial, patients with obesity undergoing LSG received either bilateral ultrasound-guided RSB performed by an anesthesiologist or LIA administered by a surgeon, following anesthesia induction. The primary outcome was intraoperative fentanyl consumption. Secondary outcomes included postoperative pain scores [Numeric Rating Scale (NRS), 0–10], cumulative morphine consumption, and recovery metrics over 48 h. Results: Sixty-nine patients were analyzed (RSB: 35; LIA: 34). Intraoperative fentanyl use was lower with RSB (median difference: − 25 mcg; 95% CI: − 50 to 0; p = 0.008). RSB reduced pain scores at rest at 0 h (–2 points; p = 0.001), 1 h (–1 point; p = 0.009), and 12 h (–1 point; p = 0.022), and pain during movement at 0 h (–3 points; p < 0.001), 12 h (–1 point; p = 0.043), and 36 h (–1 point; p = 0.019). Pain scores were otherwise comparable. Fewer RSB patients reported moderate-to-severe pain at 0 h and 1 h (rest: p = 0.006 and 0.019; movement: p < 0.001 and 0.033). Postoperative morphine use and recovery metrics were similar between groups. Conclusion: Pre-incisional RSB demonstrated an intraoperative opioid-sparing effect and superior early postoperative analgesia compared with LIA, supporting its role as a component of multimodal analgesia for LSG.